These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 9178098)
1. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines. Miotti S; Bagnoli M; Ottone F; Tomassetti A; Colnaghi MI; Canevari S J Cell Biochem; 1997 Jun; 65(4):479-91. PubMed ID: 9178098 [TBL] [Abstract][Full Text] [Related]
2. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. Corona G; Giannini F; Fabris M; Toffoli G; Boiocchi M Int J Cancer; 1998 Jan; 75(1):125-33. PubMed ID: 9426700 [TBL] [Abstract][Full Text] [Related]
3. Role of membrane folate-binding protein in the cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cell lines in vitro. Sen S; Erba E; D'Incalci M; Bottero F; Canevari S; Tomassetti A Br J Cancer; 1996 Feb; 73(4):525-30. PubMed ID: 8595169 [TBL] [Abstract][Full Text] [Related]
4. Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor. Theti DS; Bavetsias V; Skelton LA; Titley J; Gibbs D; Jansen G; Jackman AL Cancer Res; 2003 Jul; 63(13):3612-8. PubMed ID: 12839949 [TBL] [Abstract][Full Text] [Related]
5. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor. Wang X; Jansen G; Fan J; Kohler WJ; Ross JF; Schornagel J; Ratnam M Biochemistry; 1996 Dec; 35(50):16305-12. PubMed ID: 8973205 [TBL] [Abstract][Full Text] [Related]
6. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
7. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate. Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804 [TBL] [Abstract][Full Text] [Related]
8. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate. Yang R; Kolb EA; Qin J; Chou A; Sowers R; Hoang B; Healey JH; Huvos AG; Meyers PA; Gorlick R Clin Cancer Res; 2007 May; 13(9):2557-67. PubMed ID: 17473184 [TBL] [Abstract][Full Text] [Related]
9. Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo. Miotti S; Facheris P; Tomassetti A; Bottero F; Bottini C; Ottone F; Colnaghi MI; Bunni MA; Priest DG; Canevari S Int J Cancer; 1995 Nov; 63(3):395-401. PubMed ID: 7591238 [TBL] [Abstract][Full Text] [Related]
10. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells. Spinella MJ; Brigle KE; Sierra EE; Goldman ID J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875 [TBL] [Abstract][Full Text] [Related]
11. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion. Wang J; Shen F; Yan W; Wu M; Ratnam M Biochemistry; 1997 Nov; 36(47):14583-92. PubMed ID: 9398177 [TBL] [Abstract][Full Text] [Related]
12. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity. Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282 [TBL] [Abstract][Full Text] [Related]
13. Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies. Figini M; Ferri R; Mezzanzanica D; Bagnoli M; Luison E; Miotti S; Canevari S Gene Ther; 2003 Jun; 10(12):1018-25. PubMed ID: 12776159 [TBL] [Abstract][Full Text] [Related]
14. Functional effect of point mutations in the alpha-folate receptor gene of CABA I ovarian carcinoma cells. Mangiarotti F; Miotti S; Galmozzi E; Mazzi M; Sforzini S; Canevari S; Tomassetti A J Cell Biochem; 2001; 81(3):488-98. PubMed ID: 11255231 [TBL] [Abstract][Full Text] [Related]
15. UMSCC38 cells amplified at 11q13 for the folate receptor synthesize a mutant nonfunctional folate receptor. Orr RB; Kamen BA Cancer Res; 1994 Jul; 54(14):3905-11. PubMed ID: 8033114 [TBL] [Abstract][Full Text] [Related]
16. The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs. Theti DS; Jackman AL Clin Cancer Res; 2004 Feb; 10(3):1080-9. PubMed ID: 14871988 [TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated folate accumulation is regulated by the cellular folate content. Kamen BA; Capdevila A Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5983-7. PubMed ID: 3461471 [TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta. Shen F; Zheng X; Wang J; Ratnam M Biochemistry; 1997 May; 36(20):6157-63. PubMed ID: 9166787 [TBL] [Abstract][Full Text] [Related]
19. Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression. Bagnoli M; Tomassetti A; Figini M; Flati S; Dolo V; Canevari S; Miotti S Oncogene; 2000 Sep; 19(41):4754-63. PubMed ID: 11032026 [TBL] [Abstract][Full Text] [Related]